Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Pediatrics ; 147(2)2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33495367

RESUMO

Advances in science are fundamentally changing the way we understand how inextricable interactions among genetic predispositions, physical and social environments, and developmental timing influence early childhood development and the foundations of health and how significant early adversity can lead to a lifetime of chronic health impairments. This article and companion article illustrate the extent to which differential outcomes are shaped by ongoing interactive adaptations to context that begin at or even before conception and continue throughout life, with increasing evidence pointing to the importance of the prenatal period and early infancy for the developing brain, the immune system, and metabolic regulation. Although new discoveries in the basic sciences are transforming tertiary medical care and producing breakthrough outcomes in treating disease, this knowledge is not being leveraged effectively to inform new approaches to promoting whole-child development and preventing illness. The opportunity for pediatrics to serve as the leading edge of science-based innovation across the early childhood ecosystem has never been more compelling. In this article, we present a framework for leveraging the frontiers of scientific discovery to inform new strategies in pediatric practice and advocacy to protect all developing biological systems from the disruptive effects of excessive early adversity beyond providing information on child development for parents and enriched learning experiences for young children.


Assuntos
Experiências Adversas da Infância , Desenvolvimento Infantil , Saúde da Criança , Proteção da Criança , Pediatria/métodos , Resiliência Psicológica , Biologia de Sistemas , Experiências Adversas da Infância/prevenção & controle , Experiências Adversas da Infância/psicologia , Criança , Desenvolvimento Infantil/fisiologia , Pré-Escolar , Ecossistema , Meio Ambiente , Relações Familiares , Humanos , Lactente , Recém-Nascido , Apego ao Objeto , Atenção Primária à Saúde/métodos , Determinantes Sociais da Saúde , Meio Social , Transtornos de Estresse Traumático/etiologia , Transtornos de Estresse Traumático/fisiopatologia , Transtornos de Estresse Traumático/psicologia , Transtornos de Estresse Traumático/terapia , Estresse Fisiológico/fisiologia , Estresse Psicológico/etiologia , Estresse Psicológico/fisiopatologia , Estresse Psicológico/psicologia , Estresse Psicológico/terapia , Teoria de Sistemas
2.
Behav Brain Res ; 293: 227-33, 2015 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-26225843

RESUMO

D-cycloserine (DCS), an FDA approved anti-tuberculosis drug has extensively been studied for its cognitive enhancer effects in psychiatric disorders. DCS may enhance the effects of fear extinction trainings in animals during exposure therapy and hence we investigated the effects of DCS on distinct behavioral parameters in a predator odor stress model and tested the optimal duration for repeated daily administrations of the agent. Cat fur odor blocks were used to produce stress and avoidance and risk assessment behavioral parameters were used where DCS or saline were used as treatments in adjunct to extinction trainings. We observed that DCS facilitated extinction training by providing further extinction of avoidance responses, risk assessment behaviors and increased the contact with the cue in a setting where DCS was administered before extinction trainings for 3 days without producing a significant tolerance. In amygdala and hippocampus, GluN1 protein expressions decreased 72h after the fear conditioning in the traumatic stress group suggesting a possible down-regulation of NMDARs. We observed that extinction learning increased GluN1 proteins both in the amygdaloid complex and the dorsal hippocampus of the rats receiving extinction training or extinction training with DCS. Our findings also indicate that DCS with extinction training increased GluN1 protein levels in the frontal cortex. We may suggest that action of DCS relies on enhancement of the consolidation of fear extinction in the frontal cortex.


Assuntos
Antimetabólitos/uso terapêutico , Aprendizagem da Esquiva/efeitos dos fármacos , Ciclosserina/uso terapêutico , Lobo Frontal/efeitos dos fármacos , Receptores de N-Metil-D-Aspartato/metabolismo , Transtornos de Estresse Traumático/tratamento farmacológico , Análise de Variância , Animais , Gatos , Modelos Animais de Doenças , Extinção Psicológica/efeitos dos fármacos , Feminino , Reação de Congelamento Cataléptica/efeitos dos fármacos , Lobo Frontal/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Masculino , Odorantes , Ratos , Ratos Wistar , Reflexo de Estiramento/efeitos dos fármacos , Medição de Risco , Transtornos de Estresse Traumático/patologia , Transtornos de Estresse Traumático/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA